Development of blood transfusion product pathogen reduction treatments: a review of methods, current applications and demands

V Salunkhe, PF Van der Meer, D de Korte… - … and Apheresis Science, 2015 - Elsevier
Transfusion-transmitted infections (TTI) have been greatly reduced in numbers due to the
strict donor selection and screening procedures, ie the availability of technologies to test …

Impact of different pathogen reduction technologies on the biochemistry, function, and clinical effectiveness of platelet concentrates: An updated view during a …

G Escolar, M Diaz‐Ricart, J McCullough - Transfusion, 2022 - Wiley Online Library
Standard platelet concentrates (PCs) stored at 22° C have a limited shelf life of 5 days.
Because of the storage temperature, bacterial contamination of PCs can result in life …

Proteome changes in platelets after pathogen inactivation—an interlaboratory consensus

M Prudent, A D'Alessandro, JP Cazenave… - Transfusion medicine …, 2014 - Elsevier
Pathogen inactivation (PI) of platelet concentrates (PCs) reduces the proliferation/replication
of a large range of bacteria, viruses, and parasites as well as residual leucocytes. Pathogen …

[HTML][HTML] Cell-derived microparticles in stored blood products: innocent-bystanders or effective mediators of post-transfusion reactions?

A Kriebardis, M Antonelou, K Stamoulis… - Blood …, 2012 - ncbi.nlm.nih.gov
Plasma membrane-derived microvesicles or microparticles (MPs) are sub-cellular vesicles
released upon shear stress, cell activation, injury or apoptosis. They represent factors of the …

Proteomic analysis of extracellular vesicles derived from platelet concentrates treated with Mirasol® identifies biomarkers of platelet storage lesion

L Hermida-Nogueira, MN Barrachina, I Izquierdo… - Journal of …, 2020 - Elsevier
In blood banks, platelets are stored until 7 days after a pathogen reduction technology (PRT)
treatment, Mirasol®(vitamin B 2 plus UVB light) in the present case. The storage time under …

Evaluation of the effectiveness of a pathogen inactivation technology against clinically relevant transfusion‐transmitted bacterial strains

M Schmidt, MK Hourfar, W Sireis, U Pfeiffer… - …, 2015 - Wiley Online Library
BACKGROUND To increase blood safety, various procedures are currently implemented,
including donor selection, optimized donor arm disinfection, and diversion. In addition …

[HTML][HTML] Biomolecular consequences of platelet pathogen inactivation methods

HB Feys, B Van Aelst, V Compernolle - Transfusion medicine reviews, 2019 - Elsevier
Pathogen inactivation (PI) for platelet concentrates (PC) is a fairly recent development in
transfusion medicine that is intended to decrease infectious disease transmission from the …

Ultraviolet-based pathogen inactivation systems: untangling the molecular targets activated in platelets

P Schubert, L Johnson, DC Marks, DV Devine - Frontiers in medicine, 2018 - frontiersin.org
Transfusions of platelets are an important cornerstone of medicine; however, recipients may
be subject to risk of adverse events associated with the potential transmission of pathogens …

A comprehensive proteomics study on platelet concentrates: Platelet proteome, storage time and Mirasol pathogen reduction technology

V Salunkhe, IM De Cuyper, P Papadopoulos… - Platelets, 2019 - Taylor & Francis
Platelet concentrates (PCs) represent a blood transfusion product with a major concern for
safety as their storage temperature (20–24° C) allows bacterial growth, and their maximum …

Redox proteomics and platelet activation: understanding the redox proteome to improve platelet quality for transfusion

G Sonego, M Abonnenc, JD Tissot, M Prudent… - International journal of …, 2017 - mdpi.com
Blood banks use pathogen inactivation (PI) technologies to increase the safety of platelet
concentrates (PCs). The characteristics of PI-treated PCs slightly differ from those of …